Growing the love for investing
Results 31 - 40 of 121 : Previous 1 2 3 4 5 6 7 8 9 Next
The 10 Best Values in Pharma and Biotech
How to avoid the low-growth, high-risk value trap.
That's What You Call Product Differentiation?
Endo Pharma misses the mark.
Should You Sell Allergan Right Now?
We're seeking danger signs among Fools' most beloved stocks.
Why the Street Should Love King Pharmaceuticals' Earnings
All cash flow is not created equal.
Investor sentiment is growing behind these stocks.
The 10 Best Values in Pharma and Biotech
How to avoid the low-growth, high-risk value trap.
Generic growth by Endo Pharmaceuticals.
Will Endo Pharmaceuticals Holdings Whiff on Revenues Next Quarter?
Look here for a clue.
What's the Margin Trend at Endo Pharmaceuticals Holdings?
Keep your eye on margins.
Is King Pharmaceuticals a Cash Machine?
All cash flow is not created equal.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK